Financial conflicts of interest among US physician authors of 2020 clinical practice guidelines: a cross-sectional study
- PMID: 36690402
- PMCID: PMC9872463
- DOI: 10.1136/bmjopen-2022-069115
Financial conflicts of interest among US physician authors of 2020 clinical practice guidelines: a cross-sectional study
Abstract
Objective: To evaluate the prevalence and accuracy of industry-related financial conflict of interest (COI) disclosures among US physician guideline authors.
Design: Cross-sectional study.
Setting: Clinical practice guidelines published by the Council of Medical Specialty Societies in 2020.
Participants: US physician guideline authors.
Main outcome measures: Financial COI disclosures, both self-reported and determined using Open Payments data.
Results: Among 270 US physician authors of 20 clinical practice guidelines, 101 (37.4%) disclosed industry-related financial COIs, whereas 199 (73.7%) were found to have received payments from industry when accounting for payments disclosed through Open Payments. The median payments received by authors during the 3-year period was US$27 451 (IQR, US$1385-US$254 677). Comparing authors' self-disclosures with Open Payments, 72 (26.7%) of the authors accurately disclosed their financial COIs, including 68 (25.2%) accurately disclosing no financial COIs and 4 (1.5%) accurately disclosing a financial COI. In contrast, 101 (37.4%) disclosed no financial COIs and were found to have received payments from industry, 23 (8.5%) disclosed a financial COI but had under-reported payments received from industry, 14 (5.2%) disclosed a financial COI but had over-reported payments received from industry and 60 (22.2%) disclosed a financial COI but were found to have both under-reported and over-reported payments received from industry. We found that inaccurate COI disclosure was more frequent among professors compared with non-professors (81.9% vs 63.5%; p<0.001) and among males compared with females (77.7% vs 64.8%; p=0.02). The accuracy of disclosures also varied among medical professional societies (p<0.001).
Conclusions: Financial relationships with industry are common among US physician authors of clinical practice guidelines and are often not accurately disclosed. To ensure high-quality guidelines and unbiased recommendations, more effort is needed to minimise existing COIs and improve disclosure accuracy among panel members.
Keywords: MEDICAL ETHICS; Protocols & guidelines; Quality in health care.
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: MM, RR and JSR currently receive research support through Yale University from Arnold Ventures. RR currently receives research support through Yale Law School from the Stavros Niarchos Foundation for a project focused on public R&D and manufacturing for enabling equitable access to medical technologies. She also serves as a consultant to the ReAct-Action on Antibiotic Resistance Strategic Policy Program based out of Johns Hopkins Bloomberg School of Public Health, which is funded by the Swedish International Development and Cooperation Agency (Sida). JSR currently receives research support through Yale University from Johnson and Johnson to develop methods of clinical trial data sharing, from the Medical Device Innovation Consortium as part of the National Evaluation System for Health Technology, from the Food and Drug Administration for the Yale-Mayo Clinic Center for Excellence in Regulatory Science and Innovation program (U01FD005938), from the Agency for Healthcare Research and Quality (R01HS022882) and from the National Heart, Lung and Blood Institute of the National Institutes of Health (R01HS025164, R01HL144644); in addition, JSR is an expert witness at the request of Relator's attorneys, the Greene Law Firm, in a qui tam suit alleging violations of the False Claims Act and Anti-Kickback Statute against Biogen.
Figures
Similar articles
-
Financial Disclosures Reported by Industry Among Authors of the American Academy of Ophthalmology Clinical Practice Guidelines.JAMA Ophthalmol. 2023 Apr 1;141(4):378-383. doi: 10.1001/jamaophthalmol.2023.0267. JAMA Ophthalmol. 2023. PMID: 36928457 Free PMC article.
-
Evaluation of Pharmaceutical Company Payments and Conflict of Interest Disclosures Among Oncology Clinical Practice Guideline Authors in Japan.JAMA Netw Open. 2019 Apr 5;2(4):e192834. doi: 10.1001/jamanetworkopen.2019.2834. JAMA Netw Open. 2019. PMID: 31026027 Free PMC article.
-
A cross-sectional examination of conflict-of-interest disclosures of physician-authors publishing in high-impact US medical journals.BMJ Open. 2022 Apr 11;12(4):e057598. doi: 10.1136/bmjopen-2021-057598. BMJ Open. 2022. PMID: 35410932 Free PMC article.
-
Industry-specific Patterns in the Disclosure of Conflicts of Interest in Hand and Upper Extremity Surgery: A Review of the Nerve Allograft Industry.J Am Acad Orthop Surg. 2022 Nov 15;30(22):1083-1089. doi: 10.5435/JAAOS-D-22-00326. Epub 2022 Aug 16. J Am Acad Orthop Surg. 2022. PMID: 36001882 Review.
-
Reviewing the Reviewers Potential Financial Conflicts of Interest in Editorial Boards of Surgery Journals.Ann Surg. 2022 Dec 1;276(6):e1089-e1094. doi: 10.1097/SLA.0000000000004929. Epub 2021 Jun 2. Ann Surg. 2022. PMID: 34091509 Review.
Cited by
-
Trust in Physicians and Hospitals During the COVID-19 Pandemic in a 50-State Survey of US Adults.JAMA Netw Open. 2024 Jul 1;7(7):e2424984. doi: 10.1001/jamanetworkopen.2024.24984. JAMA Netw Open. 2024. PMID: 39083270 Free PMC article.
-
Funding of evidence included within public comments submitted to inform Medicare national coverage determinations.Health Aff Sch. 2024 May 13;2(6):qxae064. doi: 10.1093/haschl/qxae064. eCollection 2024 Jun. Health Aff Sch. 2024. PMID: 38919964 Free PMC article.
-
Reply to the Letter to the Editor: On Patient Safety: It Is Time to Rethink Gabapentin.Clin Orthop Relat Res. 2025 Apr 9;483(7):1363-1364. doi: 10.1097/CORR.0000000000003492. Clin Orthop Relat Res. 2025. PMID: 40208071 No abstract available.
-
Industry payments to American Society of Hematology Clinical Practice Guideline authors.Blood Adv. 2024 Jul 9;8(13):3549-3552. doi: 10.1182/bloodadvances.2023012527. Blood Adv. 2024. PMID: 38569136 Free PMC article.
-
Extent, transparency and impact of industry funding for pelvic mesh research: a review of the literature.Res Integr Peer Rev. 2024 Apr 30;9(1):4. doi: 10.1186/s41073-024-00145-9. Res Integr Peer Rev. 2024. PMID: 38685078 Free PMC article.
References
-
- Graham R, Mancher M, Miller Wolman D, et al. . Institute of medicine committee on standards for developing trustworthy clinical practice G. In: Clinical practice guidelines we can trust. Washington (DC): National Academies Press (US), 2011. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources